The tumor suppressor p53 abrogates Smad-dependent collagen gene induction in mesenchymal cells

作者: Asish K. Ghosh , Swati Bhattacharyya , John Varga

DOI: 10.1074/JBC.M403477200

关键词: FibrosisCancer researchSMADEctopic expressionCytokineGene expressionTransforming growth factorType I collagenRepressorBiology

摘要: The pleiotropic cytokine transforming growth factor-β (TGF-β) is a potent inducer of collagen synthesis and implicated in the pathogenesis fibrosis. Acting concert with transcriptional coactivators p300/CBP, Smads mediate TGF-β stimulation human dermal fibroblasts. Little information exists regarding positive negative modulation physiological responses. Because tumor suppressor p53 connective tissue homeostasis, here we examined regulation gene expression by p53. Forced ectopic fibroblasts repressed basal TGF-β-stimulated expression, whereas absence cellular was associated significantly enhanced activity Type I (COL1A2) synthesis. Ectopic also promoter driven minimal Smad-binding elements, suggesting that modulated Smad-dependent intracellular signaling. Inhibition not due to altered levels, phosphorylation, or nuclear translocation Smads. Treatment etoposide, p53, abrogated COL1A2 p53-dependent manner. Overexpression coactivator p300 rescued overexpressing Furthermore, ligand-induced interaction Smad3 its cognate DNA element recruitment DNA-protein complex assembled on were markedly reduced p53-overexpressing Collectively, these results indicate, for first time, selective endogenous repressor TGF-β-regulated ligand-dependent may be one targets p53-mediated inhibition These findings suggest novel important physiologic function fibrotic

参考文章(52)
M.R. Keeton, S.A. Curriden, A.J. van Zonneveld, D.J. Loskutoff, Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. Journal of Biological Chemistry. ,vol. 266, pp. 23048- 23052 ,(1991) , 10.1016/S0021-9258(18)54461-6
Wei Gu, Xiao-Lu Shi, Robert G. Roeder, Synergistic activation of transcription by CBP and p53 Nature. ,vol. 387, pp. 819- 823 ,(1997) , 10.1038/42972
Sosamma J. Berger, Cecilia M. Whitacre, Satadal Chatterjee, Hisako Hashimoto, Nathan A Berger, Min Lung Tsai, Involvement of NAD-Poly(ADP-Ribose) Metabolism in p53 Regulation and Its Consequences Cancer Research. ,vol. 55, pp. 3697- 3701 ,(1995)
Nancy L. Lill, Steven R. Grossman, Doron Ginsberg, James DeCaprio, David M. Livingston, Binding and modulation of p53 by p300/CBP coactivators Nature. ,vol. 387, pp. 823- 827 ,(1997) , 10.1038/42981
Joan Boyes, Peter Byfield, Yoshihiro Nakatani, Vasily Ogryzko, Regulation of activity of the transcription factor GATA-1 by acetylation Nature. ,vol. 396, pp. 594- 598 ,(1998) , 10.1038/25166
Asish K. Ghosh, Factors involved in the regulation of type I collagen gene expression: Implication in fibrosis Experimental Biology and Medicine. ,vol. 227, pp. 301- 314 ,(2002) , 10.1177/153537020222700502
Sarah Smolik, Richard H. Goodman, CBP/p300 in cell growth, transformation, and development Genes & Development. ,vol. 14, pp. 1553- 1577 ,(2000) , 10.1101/GAD.14.13.1553
Nicholas B. La Thangue, Ho Man Chan, p300/CBP proteins: HATs for transcriptional bridges and scaffolds Journal of Cell Science. ,vol. 114, pp. 2363- 2373 ,(2001) , 10.1242/JCS.114.13.2363
M. Levrero, V. De Laurenzi, A Costanzo, S Sabatini, J Gong, JYJ Wang, G Melino, The p53/p63/p73 family of transcription factors: overlapping and distinct functions Journal of Cell Science. ,vol. 113, pp. 1661- 1670 ,(2000) , 10.1242/JCS.113.10.1661